HLS Therapeutics, Inc. (HLS.TO)
4.09
-0.11
(-2.62%)
CAD |
TSX |
Oct 09, 16:00
HLS Therapeutics Price : 4.09 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 4.17 | 4.35 | 4.09 | 4.09 | 142079.0 |
| Oct 08, 2026 | 4.29 | 4.29 | 4.20 | 4.20 | 33088.00 |
| Oct 07, 2026 | 4.24 | 4.33 | 4.155 | 4.25 | 20388.00 |
| Oct 06, 2026 | 4.43 | 4.43 | 4.16 | 4.20 | 68728.00 |
| Oct 05, 2026 | 3.90 | 4.25 | 3.90 | 4.21 | 437761.0 |
| Oct 02, 2026 | 4.00 | 4.11 | 3.86 | 3.87 | 51573.00 |
| Oct 01, 2026 | 4.17 | 4.20 | 3.75 | 3.89 | 388910.0 |
| Sep 30, 2026 | 4.00 | 4.20 | 4.00 | 4.20 | 104828.0 |
| Sep 29, 2026 | 4.02 | 4.02 | 3.95 | 3.99 | 19136.00 |
| Sep 28, 2026 | 3.99 | 4.01 | 3.99 | 4.00 | 28191.00 |
| Sep 25, 2026 | 4.00 | 4.04 | 3.94 | 4.02 | 370338.0 |
| Sep 24, 2026 | 3.92 | 4.00 | 3.91 | 3.94 | 49895.00 |
| Sep 23, 2026 | 4.00 | 4.00 | 3.86 | 3.95 | 12599.00 |
| Sep 22, 2026 | 3.97 | 4.01 | 3.96 | 3.96 | 8730.00 |
| Sep 21, 2026 | 4.00 | 4.02 | 3.95 | 3.97 | 14106.00 |
| Sep 18, 2026 | 4.01 | 4.02 | 3.91 | 3.91 | 27494.00 |
| Sep 17, 2026 | 4.05 | 4.05 | 3.99 | 3.99 | 8502.00 |
| Sep 16, 2026 | 4.00 | 4.06 | 4.00 | 4.03 | 1618.00 |
| Sep 15, 2026 | 4.15 | 4.205 | 4.07 | 4.09 | 241861.0 |
| Sep 14, 2026 | 3.90 | 4.18 | 3.90 | 4.15 | 54491.00 |
| Sep 11, 2026 | 3.72 | 3.975 | 3.70 | 3.90 | 144351.0 |
| Sep 10, 2026 | 3.93 | 3.93 | 3.72 | 3.73 | 30665.00 |
| Sep 09, 2026 | 3.75 | 3.86 | 3.73 | 3.75 | 17200.00 |
| Sep 08, 2026 | 3.76 | 3.90 | 3.74 | 3.78 | 16260.00 |
| Sep 04, 2026 | 3.65 | 3.77 | 3.60 | 3.70 | 68582.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Bausch Health Cos., Inc. | 8.64 |
| Cipher Pharmaceuticals, Inc. | 13.65 |
| BioSyent, Inc. | 17.15 |
| Revive Therapeutics Ltd. | 0.025 |
| Knight Therapeutics, Inc. | 10.83 |
Price Related Metrics
| PS Ratio | 1.647 |
| Price to Book Value | 1.632 |
| Price to Free Cash Flow | 5.858 |
| Earnings Yield | -9.22% |
| Market Cap | 127.89M |